跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BESREMI 250 MICROGRAMOS/0,5 ML DE SOLUCION PARA INYECCION EN PLUMA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BESREMI 250 MICROGRAMOS/0,5 ML DE SOLUCION PARA INYECCION EN PLUMA PRECARGADA
Approved
STANDARD
BESREMI 250 MICROGRAMOS/0,5 ML DE SOLUCION PARA INYECCION EN PLUMA PRECARGADA
Aop Orphan Pharmaceuticals Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 10, 2021
Approval ID
7bb5aa56460e2ade
Company
Aop Orphan Pharmaceuticals Gmbh
Type
Standard
Approval Details
Approval Id
7bb5aa56460e2ade
Drug Cima Aemps Name
BESREMI 250 MICROGRAMOS/0,5 ML DE SOLUCION PARA INYECCION EN PLUMA PRECARGADA
Register Number
1181352001
Holder Company Name
Aop Orphan Pharmaceuticals Gmbh
Marketing Company Name
Aop Orphan Pharmaceuticals Iberia, S.L.U
Holder Company Detail Path
/organization/aop-orphan-pharmaceuticals-gmbh
Authorization Date
2021-12-10
Dosage Form
SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA
Dose
250 microgramos/0,5 ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Aop Orphan Pharmaceuticals Gmbh
Company Detail Path
/organization/aop-orphan-pharmaceuticals-gmbh
Company Information
Pharmaceutical Company Name
AOP Orphan Pharmaceuticals GmbH
Country Name
Austria
City Name
wien,wien,country_at
Address
Leopold Ungar Platz 2
Website
http://www.aoporphan.com
Active Ingredients
ROPEGINTERFERON ALFA-2B
0,5 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 10, 2021
Approval ID
7bb5aa56460e2ade
Type
Standard
Back to CIMA-AEMPS Approvals